SCHEMBL888653

SCHEMBL888653

CNC(=O)c1ccc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28029054 0.98 — —
SCHEMBL14742539 0.88 KDM4E (0.44) —
Edetic Acid SCHEMBL7538782 0.82 TSHR (0.44) —
SCHEMBL5204640 0.80 — —
1-Methylimidazole SCHEMBL6040916 0.80 CD38 (0.42) —
SCHEMBL3699321 0.78 — —
SCHEMBL2569547 0.78 — —
SCHEMBL18953099 0.78 — —
SCHEMBL161785 0.78 KDM4E (0.49) —
SCHEMBL2449027 0.78 KDM4E (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682135-B2 Drug delivery product and methods UNIVERSITY OF MASSACHUSETTS (US) 2017-06-20 — — US claimed
US-9382197-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-05 — — US claimed
US-20140335047-A1 DRUG DELIVERY PRODUCT AND METHODS UNIVERSITY OF MASSACHUSETTS (US) 2014-11-13 — — US claimed
US-8546588-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-10-01 — — US claimed
EP-1755567-B1 DRUG DELIVERY PRODUCT AND METHODS UNIV MASSACHUSETTS (US) 2010-11-03 — — EP claimed
CN-101001615-A Drug delivery product and method NEXMED HOLDINGS INC (US) 2007-07-18 — — CN claimed
US-20070054276-A1 Polynucleotide analysis and methods of using nanopores AGILENT TECHNOLOGIES, INC. 2007-03-08 — — US claimed
EP-1755567-A2 DRUG DELIVERY PRODUCT AND METHODS Nexmed Holdings, Inc. (US) 2007-02-28 — — EP claimed
CN-1267419-C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethionamides as fungicides SYNGENTA PARTICIPATIONS AG (CH) 2006-08-02 — — CN claimed
WO-2006007372-A2 DRUG DELIVERY PRODUCT AND METHODS OSTROFF GARY R (US) 2006-01-19 — — WO claimed
US-20030211508-A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor GENESOFT, INC. 2003-11-13 — — US claimed
EP-1265921-A1 CHARGED COMPOUNDS COMPRISING A NUCLEIC ACID BINDING MOIETY AND USES THEREFOR Genesoft, Inc. (US) 2002-12-18 — — EP claimed
US-20020065227-A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor GENESOFT PHARMACEUTICALS, INC. 2002-05-30 — — US claimed
WO-2001074898-A2 CHARGED COMPOUNDS COMPRISING A NUCLEIC ACID BINDING MOIETY AND USES THEREFOR GENESOFT, INC. (US) 2001-10-11 — — WO claimed
CN-1311774-A Trifluoromethyl pyrrole carboxamides SINGENTA INVOLVEMENT CO LTD (CH) 2001-09-05 — — CN claimed
US-6090947-A Method for the synthesis of pyrrole and imidazole carboxamides on a solid support CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-07-18 — — US claimed
EP-0986539-A1 DNA-BINDING PYRROLE AND IMIDAZOLE POLYAMIDE DERIVATIVES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-03-22 — — EP claimed
US-5955590-A OLIGONUCLEOTIDE COVALENTLY COUPLED TO PEPTIDE OF N-METHYLPYRROLECARBOXAMIDES; FOR STABILIZING HYBRIDIZATION COMPLEXES IN ANTISENSE THERAPY AND DNA DETECTION SYSTEMS USING PROBES WORCESTER FOUNDATION FOR BIOMEDICAL RESEARCH (US) 1999-09-21 — — US claimed
WO-1998049142-A1 DNA-BINDING PYRROLE AND IMIDAZOLE POLYAMIDE DERIVATIVES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 1998-11-05 — — WO claimed
WO-1998002448-A1 CONJUGATES OF MINOR GROOVE DNA BINDERS WITH ANTISENSE OLIGONUCLEOTIDES UNIVERSITY OF MASSACHUSETTS (US) 1998-01-22 — — WO claimed
Send feedback